InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,524.00
(
0.60%
)
Dow Jones
38,834.86
(
0.00%
)
Brent Oil
84.72
(
0.02%
)
Bitcoin
66,217.72
(
1.92%
)
Post# of 252256
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: iwfal post# 137136

Thursday, 02/16/2012 3:24:39 PM

Thursday, February 16, 2012 3:24:39 PM

Post# of 252256
Diabetes treatments with new methods of action

TAK-875 - a GPR40 agonist is in phase III trials:

http://www.takeda.com/press/article_43205.html

There are several glucokinase activators in clinical trials (think that AZD1656 is the most advanced now after LLY terminated and Roch is on hold).
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up